144 related articles for article (PubMed ID: 1832761)
1. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
Panfilov V; Morris AD; Donnelly R; Reid JL
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
[TBL] [Abstract][Full Text] [Related]
3. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
Scemama M; Février B; Beucler I; Dairou F
Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
[TBL] [Abstract][Full Text] [Related]
4. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Widimský J; Sirotiaková J
Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
[TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
Wilkinson R; Mansy S; Corcoran C
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
Fiorentini C; Guillet C; Guazzi M
Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
[TBL] [Abstract][Full Text] [Related]
9. How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.
Konrady AO; Kasherininov YR; Shavarov AA; Shavarova EK; Vachrameeva NV; Krutikov AN; Smirnova EV; Shlyakhto EV
J Hum Hypertens; 2006 Jun; 20(6):398-406. PubMed ID: 16543910
[TBL] [Abstract][Full Text] [Related]
10. [Pharmaco-epidemiologic evaluation of rilmenidine in 18,235 hypertensive patients].
Luccioni R
Presse Med; 1995 Dec; 24(38):1857-64. PubMed ID: 8545441
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
Widimský J
Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
De Luca N; Izzo R; Fontana D; Iovino G; Argenziano L; Vecchione C; Trimarco B
J Hypertens; 2000 Oct; 18(10):1515-22. PubMed ID: 11057441
[TBL] [Abstract][Full Text] [Related]
14. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
15. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
16. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.
Buranakitjaroen P; Kittipawong P; Koanantakul B; Piamsomboon C; Prasassarakich N; Silaraks S; Sukonthasarn A; Tiyapant A;
J Med Assoc Thai; 2003 Oct; 86(10):903-10. PubMed ID: 14650701
[TBL] [Abstract][Full Text] [Related]
18. Effort blood pressure control in the course of antihypertensive treatment.
de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
[TBL] [Abstract][Full Text] [Related]
19. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
Reid JL; Panfilov V; MacPhee G; Elliott HL
Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]